-
Product Insights
Intermittent Claudication - Drugs In Development, 2024
Empower your strategies with our Intermittent Claudication – Drugs In Development, 2024 report and make more profitable business decisions. Intermittent claudication is caused by a narrowing or blockage in the main artery that takes blood to leg. Symptoms include burning or tingling sensation, decreased or absent pulse in the lower limb, pale or bluish skin, poor hair growth on the legs, and sores or wounds on the lower limb that heal slowly or poorly. Risk factors include smoking, high cholesterol, high...
-
Product Insights
Thromboembolic Disease - Drugs In Development, 2024
Empower your strategies with our Thromboembolic Disease – Drugs In Development, 2024 report and make more profitable business decisions. Thromboembolism is a condition in which a a thrombus (blood clot) detaches and blocks the blood vessel (embolizes). Venous thromboembolism can lead to two types of conditions: deep vein thrombosis (DVT) and pulmonary embolism (PE). Risk factors that contribute to VTE are injury to vein, infection, immobilization, high estrogen, smoking, obesity, age, chronic illness, and blood clotting conditions. Signs and symptoms include...
-
Product Insights
Aneurysm - Drugs In Development, 2024
Empower your strategies with our Aneurysm – Drugs In Development, 2024 report and make more profitable business decisions. An aneurysm is a weak or expanded bulge in the wall of an artery. The different types are abdominal aortic aneurysm (AAA), cerebral aneurysms, thoracic aortic aneurysm, and carotid, popliteal, mesenteric, and splenic aneurisms. Atherosclerosis, family history of aneurysm, high blood pressure, and injury to the aorta can be the causative parameters. Symptoms include lightheadedness; tachycardia; sudden, severe pain in the head, chest...
-
Product Insights
Thrombotic Microangiopathy - Drugs In Development, 2024
Empower your strategies with our Thrombotic Microangiopathy – Drugs In Development, 2024 report and make more profitable business decisions. Thrombotic Microangiopathy is a life-threatening group of hematological diseases characterized by hemolytic anemia (destruction of red blood cells), thrombocytopenia, and microthrombi leading to ischemic tissue injury. In severe cases, TMA leads to kidney injury. Mutations in the ADAMTS13 gene and atypical hemolytic uremic syndrome cause TMA. It can also be caused by infectious diseases, blood-borne diseases, drug-induced etc. Complete blood count to...
-
Product Insights
Arterial Thrombosis - Drugs In Development, 2024
Empower your strategies with our Arterial Thrombosis – Drugs In Development, 2024 report and make more profitable business decisions. Arterial thrombosis is a blood clot that develops in an artery. Symptoms include lack of pulse, pain or spasms in the muscles, pale skin, and coldness. Depending on where the clot forms, arterial thrombosis can cause several serious conditions, including stroke, heart attack, and peripheral arterial disease (PAD). Predisposing factors include smoking, obesity, diabetes, hypertension, and high cholesterol level. Treatment includes thrombolytic...
-
Product Insights
Congenital Heart Disease - Drugs In Development, 2024
Empower your strategies with our Congenital Heart Disease – Drugs In Development, 2024 report and make more profitable business decisions. Congenital heart disease is an impairment of the heart’s structure that is present at birth. It may change the normal flow of blood through the heart. It is the most common type of birth defect, occurring in about 1% of live births in the US. There are different types of congenital heart defects; the most common involve the inside walls of...
-
Product Insights
Cardiac Arrest - Drugs In Development, 2024
Empower your strategies with our Cardiac Arrest – Drugs In Development, 2024 report and make more profitable business decisions. Cardiac arrest occurs when the heart suddenly and unexpectedly stops pumping. If this happens, blood stops flowing to the brain and other vital organs. Cardiac arrest is a medical emergency and can be caused by certain types of arrhythmias that prevent the heart from pumping blood. The Cardiac Arrest drugs in development market research report provide comprehensive information on the therapeutics under...
-
Product Insights
Cerebral Infarction (Brain Infarction) - Drugs In Development, 2024
Empower your strategies with our Cerebral Infarction (Brain Infarction) – Drugs In Development, 2024 report and make more profitable business decisions. Cerebral infarction results in an area of necrotic tissue in the brain (a cerebral infarct). It is caused by disrupted blood supply (ischemia) and restricted oxygen supply (hypoxia), most commonly due to thromboembolism, and manifests clinically as ischemic stroke. Major risk factors for cerebral infarction are generally the same as for atherosclerosis. These include high blood pressure, diabetes mellitus, tobacco...
-
Product Insights
Ischemic Cardiomyopathy - Drugs In Development, 2024
Empower your strategies with our Ischemic Cardiomyopathy – Drugs In Development, 2024 report and make more profitable business decisions. Ischemic cardiomyopathy is a type of cardiomyopathy caused by a narrowing of the coronary arteries that supply blood to the heart. Patients with ischemic cardiomyopathy often have a history of acute myocardial infarction (MI), but it may occur in patients with coronary artery disease but no past history of acute MI. This cardiomyopathy is one of the leading causes of sudden cardiac...
-
Product Insights
Hypotension - Drugs In Development, 2024
Empower your strategies with our Hypotension – Drugs In Development, 2024 report and make more profitable business decisions. Low blood pressure, or hypotension, occurs when blood pressure during and after each heartbeat is much lower than usual. This means the heart, brain, and other parts of the body do not get enough blood. Symptoms include blurred vision, dizziness, confusion, sleeplessness, and weakness. Treatment is required for patients with signs and symptoms. The Hypotension drugs in development market research report provide comprehensive...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.